(FY)May 31, 2024 | (Q4)May 31, 2024 | (Q3)Feb 29, 2024 | (Q2)Nov 30, 2023 | (Q1)Aug 31, 2023 | (FY)May 31, 2023 | (Q4)May 31, 2023 | (Q3)Feb 28, 2023 | (Q2)Nov 30, 2022 | (Q1)Aug 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 5.64%16.71M | 5.64%16.71M | 275.26%22.57M | -3.03%8.19M | 0.20%12.29M | 1,101.57%15.82M | 1,101.57%15.82M | 165.70%6.01M | 534.90%8.45M | 578.12%12.27M |
-Cash and cash equivalents | 5.60%16.65M | 5.60%16.65M | 277.57%22.52M | -2.81%8.14M | 0.32%12.24M | 1,159.03%15.77M | 1,159.03%15.77M | 170.28%5.96M | 558.23%8.38M | 598.89%12.2M |
-Accounts receivable | 562.51%46.38K | 562.51%46.38K | 58.58%46.88K | 30.94%41.38K | -25.28%16.5K | -72.74%7K | -72.74%7K | 85.18%29.56K | 98.17%31.6K | 40.69%22.08K |
-Due from related parties current | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -9.35%142.53K | -0.00%142.53K | 0.00%142.53K |
Total current assets | 5.16%16.89M | 5.16%16.89M | 255.17%22.81M | -4.85%8.38M | 0.42%12.54M | 926.26%16.06M | 926.26%16.06M | 156.83%6.42M | 479.33%8.81M | 524.60%12.49M |
Non current assets | ||||||||||
-Accumulated depreciation | -102.26%-520.05K | -102.26%-520.05K | -112.26%-428.45K | -106.42%-361.13K | -91.10%-294.39K | -89.86%-257.12K | -89.86%-257.12K | -62.31%-201.85K | -56.39%-174.95K | -59.31%-154.04K |
-Other intangible assets | ---- | ---- | ---- | -14.56%679.66K | -14.56%679.66K | 0.00%679.66K | 0.00%679.66K | -10.73%795.51K | -35.22%795.51K | -48.43%795.51K |
Regulatory assets | 66.38%103.77K | 66.38%103.77K | -60.87%90.52K | -65.00%70.06K | -75.09%50.27K | -70.63%62.37K | -70.63%62.37K | 5.90%231.35K | 15.24%200.16K | 27.55%201.81K |
Total assets | 3.66%57.39K | 3.66%57.39K | -26.35%43.65K | 10.14%28.68K | -9.22%33.77K | 25.38%55.37K | 25.38%55.37K | 30.91%59.26K | 71.08%26.04K | --37.2K |
Liabilities | ||||||||||
Current liabilities | ||||||||||
-accounts payable | 23.38%2.41M | 23.38%2.41M | 85.94%2.77M | 21.19%2.4M | 17.68%2.18M | 134.70%1.95M | 134.70%1.95M | 60.36%1.49M | 121.51%1.98M | 134.35%1.85M |
-Total tax payable | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
-Due to related parties current | 0.00%71.19K | 0.00%71.19K | 0.00%71.19K | 12.30%79.94K | -3.71%71.19K | -47.81%71.19K | -47.81%71.19K | -9.64%71.19K | -35.32%71.19K | -68.28%73.93K |
Current liabilities | 22.55%2.48M | 22.55%2.48M | 82.02%2.84M | 20.88%2.48M | 16.86%2.25M | 108.97%2.02M | 108.97%2.02M | 54.90%1.56M | 104.29%2.05M | 88.23%1.93M |
Non current liabilities | ||||||||||
Non current accrued expenses | 72.53%47.21M | 72.53%47.21M | 73.66%41.23M | 57.97%35.12M | 62.90%30.91M | 67.53%27.36M | 67.53%27.36M | 54.76%23.74M | 61.10%22.23M | 54.89%18.97M |
Total non current liabilities | 22.55%2.48M | 22.55%2.48M | 82.02%2.84M | 20.88%2.48M | 16.86%2.25M | 108.97%2.02M | 108.97%2.02M | 54.90%1.56M | 104.29%2.05M | 88.23%1.93M |
Shareholders'equity | ||||||||||
Share capital | 25.73%106.23M | 25.73%106.23M | 49.28%106.01M | 19.87%84.99M | 20.01%84.49M | 46.03%84.49M | 46.03%84.49M | 25.23%71.02M | 29.88%70.9M | 33.56%70.4M |
-common stock | 25.73%106.23M | 25.73%106.23M | 49.28%106.01M | 19.87%84.99M | 20.01%84.49M | 46.03%84.49M | 46.03%84.49M | 25.23%71.02M | 29.88%70.9M | 33.56%70.4M |
Additional paid-in capital | 18.05%13.87M | 18.05%13.87M | 15.59%12.8M | 16.88%12.18M | 17.72%12.14M | 14.95%11.75M | 14.95%11.75M | 6.27%11.07M | 15.25%10.42M | 15.78%10.31M |
Gains losses not affecting retained earnings | 10.16%-1.19M | 10.16%-1.19M | -18.74%-1.33M | -0.21%-1.29M | 23.62%-1.2M | 35.65%-1.33M | 35.65%-1.33M | 44.01%-1.12M | 28.50%-1.29M | 16.68%-1.57M |
Total equity | 47.61%64.09M | 47.61%64.09M | 112.30%64.04M | 40.14%43.5M | 38.10%43.45M | 142.62%43.42M | 142.62%43.42M | 69.06%30.16M | 102.62%31.04M | 120.81%31.46M |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data